Association of peripheral and central arterial wave reflections with the CYP11B2-344C allele and sodium excretion

Journal of Hypertension

Volumn 22, Issue 12, 2004, Pages 2311-2319

  Wojciechowska, Wiktoria ^a   Staessen, Jan A ^b   Stolarz, Katarzyna ^a   Nawrot, Tim ^b   Filipovský, Jan ^c   Tichá, Milena ^c   Bianchi, Giuseppe ^d   Brand, Eva ^e   Cwynar, Marcin ^a   Grodzicki, Tomasz ^a   Kuznetsova, Tatiana ^b   Struijker Boudier, Harry A ^f   Svobodová, Vlasta ^c   Thijs, Lutgarde ^b   Van Bortel, Luc M ^g   Kawecka Jaszcz, Kalina ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CHARLES UNIVERSITY   (Czech Republic)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g GHENT UNIVERSITY   (Belgium)

Author keywords

Aldosterone synthase; Angiotensin converting enzyme; Augmentation index; Genetics; Sodium

Indexed keywords

ALDOSTERONE SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM;

ADULT; ALLELE; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIAL ARTERY; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 10244229628     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200412000-00013     Document Type: Article

References (34)

1. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434-438.
2. Snieder H, Hayward CS, Perks U, Kelly RP, Kelly PJ, Spector TD. Heritability of central systolic pressure augmentation a twin study. Hypertension 2000; 35:574-579.
3. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388.
4. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12:205S-213S.
5. Duprez D, De Buyzere M, Rietzschel ER, Clement DL. Aldosterone and vascular damage. Curr Hypertens Rep 2000; 2:327-334.
6. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95:1827-1836.
7. Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens 1988; 6:965-973.
8. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-711.
9. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32:198-204.
10. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods, 2nd edn. Boston, Massachusetts: MA Publishing Company; 1988, p. 585.
11. The SAS Institute. The GENMOD procedure. In: SAS Online Doc Version 7.1: SAS/STAT. Cary, North Carolina: The SAS Institute Inc.; 2000, pp. 1311-1411.
12. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66:279-292.
13. Allison DB. Transmission-disequilibrium tests for quantitative traits. Am J Hum Genet 1997; 60:676-690.
14. Brand E, Schorr U, Ringel J, Beige J, Distler A, Sharma AM. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens 1999; 17:1563-1567.
15. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 1999; 33:266-270.
16. Rice DA, Mouw AR, Bogerd AM, Parker KL. A shared promoter element regulates the expression of three steroidogeneic enzymes. Mol Endocrinol 1999; 5:1552-1561.
17. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002; 28:125-135.
18. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res 1995; 21:437-442.
19. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements. Mol Endocrinol 1997; 11:638-649.
20. Sirianni R, Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V, et al. Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J Endocrinol 2002; 174:R13-R17.
21. Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol 2000; 32:865-879.
22. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11:856-860.
23. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34:423-429.
24. Hautanena A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, et al. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 1998; 244:11-18.
25. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33:703-707.
26. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 2003; 21:1331-1337.
27. O'Rourke MF, Staessen J, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; Definitions and reference value. Am J Hypertens 2002; 15:426-444.
28. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997; 10:1326-1334.
29. Safar ME, Benetos A. Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system. Am J Hypertens 2003; 16:249-258.
30. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000; 141:1901-1904.
31. Takeda Y. Pathophysiological roles of vascular 11 beta-hydroxysteroid dehydrogenase and aldosterone. J Steroid Biochem Mol Biol 2003; 85:443-447.
32. Balkestein EJ, Staessen JA, Wang JG, Der Heijden-Spek JJ, Van Bortel LM, Barlassina C, et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001; 38:1190-1197.
33. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
34. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4:805-808.